Premium
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR SEVERE LOWER EXTREMITY ISCHAEMIA
Author(s) -
Fletcher J. P.,
Little J. M.,
Fermanis G. G.,
Simmons K.
Publication year - 1986
Publication title -
australian and new zealand journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.111
H-Index - 51
eISSN - 1445-2197
pISSN - 0004-8682
DOI - 10.1111/j.1445-2197.1986.tb01867.x
Subject(s) - medicine , percutaneous , angioplasty , amputation , angina , adverse effect , surgery , hemodynamics , ischemia , cardiology , myocardial infarction
Percutaneous transluminal angioplasty (PTA) was attempted on 70 occasions in 63 consecutive patients presenting with advanced ischacmia. The procedure was technically succcssful in 64 (91%) with hacmodynamic improvement in 39 (56%) and clinical improvement maintained at 6 months in 51 (73%). Follow‐up ranged from 6 months to 4 years and life‐table analysis showed 60% succcss at 1 year and 58% success at 2 years. Overall limbsalvage was 76%. Complications occurred in 6 (9%) and in one case this lead to amputation. The relationship of a number of associated factors to outcome was assessed. The presence of cardiac disease requiring treatment for failure or angina was a highly significant adverse factor ( P < 0.001). Decreasing age and greater extent of disease were also significant adverse factors ( P < 0.05). Therefore, because of its low morbidity and cost. PTA can be seen as a useful procedure in patients presenting with advanced peripheral vascular discase